These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14552833)

  • 1. Differential signaling by CpG DNA in DCs and B cells: not just TLR9.
    Verthelyi D; Zeuner RA
    Trends Immunol; 2003 Oct; 24(10):519-22. PubMed ID: 14552833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG-DNA as immune response modifier.
    Dalpke AH; Heeg K
    Int J Med Microbiol; 2004 Oct; 294(5):345-54. PubMed ID: 15532993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells.
    Vollmer J; Jurk M; Samulowitz U; Lipford G; Forsbach A; Wüllner M; Tluk S; Hartmann H; Kritzler A; Müller C; Schetter C; Krieg AM
    J Endotoxin Res; 2004; 10(6):431-8. PubMed ID: 15588427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
    Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
    Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9.
    Takeshita F; Gursel I; Ishii KJ; Suzuki K; Gursel M; Klinman DM
    Semin Immunol; 2004 Feb; 16(1):17-22. PubMed ID: 14751759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
    Ma C; Spies NP; Gong T; Jones CX; Chu WM
    PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways.
    Yasuda K; Yu P; Kirschning CJ; Schlatter B; Schmitz F; Heit A; Bauer S; Hochrein H; Wagner H
    J Immunol; 2005 May; 174(10):6129-36. PubMed ID: 15879108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
    Wu CC; Lee J; Raz E; Corr M; Carson DA
    J Biol Chem; 2004 Aug; 279(32):33071-8. PubMed ID: 15184382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulin is a soluble cofactor for toll-like receptor 9 signaling.
    Park B; Buti L; Lee S; Matsuwaki T; Spooner E; Brinkmann MM; Nishihara M; Ploegh HL
    Immunity; 2011 Apr; 34(4):505-13. PubMed ID: 21497117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells.
    Tsujimura H; Tamura T; Kong HJ; Nishiyama A; Ishii KJ; Klinman DM; Ozato K
    J Immunol; 2004 Jun; 172(11):6820-7. PubMed ID: 15153500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 9, CpG DNA and innate immunity.
    Ashkar AA; Rosenthal KL
    Curr Mol Med; 2002 Sep; 2(6):545-56. PubMed ID: 12243247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide.
    Chen L; Arora M; Yarlagadda M; Oriss TB; Krishnamoorthy N; Ray A; Ray P
    J Immunol; 2006 Aug; 177(4):2373-83. PubMed ID: 16887999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
    Hemmi H; Kaisho T; Takeda K; Akira S
    J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9.
    Pohar J; Lainšček D; Kunšek A; Cajnko MM; Jerala R; Benčina M
    Sci Rep; 2017 Nov; 7(1):14598. PubMed ID: 29097808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 9 mediates CpG-DNA signaling.
    Chuang TH; Lee J; Kline L; Mathison JC; Ulevitch RJ
    J Leukoc Biol; 2002 Mar; 71(3):538-44. PubMed ID: 11867692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
    Mellor AL; Baban B; Chandler PR; Manlapat A; Kahler DJ; Munn DH
    J Immunol; 2005 Nov; 175(9):5601-5. PubMed ID: 16237046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC; Kuchtey J; Harding CV
    J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.
    Tian J; Avalos AM; Mao SY; Chen B; Senthil K; Wu H; Parroche P; Drabic S; Golenbock D; Sirois C; Hua J; An LL; Audoly L; La Rosa G; Bierhaus A; Naworth P; Marshak-Rothstein A; Crow MK; Fitzgerald KA; Latz E; Kiener PA; Coyle AJ
    Nat Immunol; 2007 May; 8(5):487-96. PubMed ID: 17417641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.